Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of ensuring that the independent review into mental health conditions, ADHD and autism consults with people with lived experience across different regions such as the North East.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The independent review into prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism will appoint an advisory working group. This will be a multidisciplinary group of leading academics, clinicians, epidemiological experts, charities and people with lived experience to directly shape the recommendations and scrutinise the evidence.
Ahead of launching the independent review, my Rt Hon. Friend, the Secretary of State for Health and Social Care, held discussions with a range of mental health, ADHD, and autism stakeholders on the scope of the review.
As this is an independent review, it is therefore for the Chair and vice-chairs to consider who to consult and the relevant forums for engagement, that are relevant to deliver the terms of reference set by the Department.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of holding regional public consultation events as part of the independent review into mental health conditions, ADHD and autism.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The independent review into prevalence and support for mental health conditions, attention deficit hyperactivity disorder (ADHD), and autism will appoint an advisory working group. This will be a multidisciplinary group of leading academics, clinicians, epidemiological experts, charities and people with lived experience to directly shape the recommendations and scrutinise the evidence.
Ahead of launching the independent review, my Rt Hon. Friend, the Secretary of State for Health and Social Care, held discussions with a range of mental health, ADHD, and autism stakeholders on the scope of the review.
As this is an independent review, it is therefore for the Chair and vice-chairs to consider who to consult and the relevant forums for engagement, that are relevant to deliver the terms of reference set by the Department.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the workforce modelling used as the basis for the 10 Year Workforce Plan will be independent; and whether the results of that modelling will be independently assessed and tested.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We have committed to updating workforce modelling which will be set out in and alongside the 10 Year Workforce Plan when published in spring 2026. This will be supported by external scrutiny to independently assess and test it.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department for Education:
To ask the Secretary of State for Education, what steps she is taking to improve accessibility to higher education for people with progressive neurological conditions such as Friedreich’s ataxia.
Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)
This government is committed to ensuring that all students are supported to both access higher education (HE) and to thrive while they are there. For example, in our recent Skills White Paper we committed to significantly increasing the take-up of the Adjustment Planner. This allows all individuals to go through the support that they think would be right for them and discuss this with the people they are studying with.
It also remains the case that HE providers have responsibilities under the Equality Act 2010 to make reasonable adjustments for all their disabled students.
Wherever possible, disabled students should expect to have their needs met through inclusive learning practices and individual reasonable adjustments made by their provider.
In addition to reasonable adjustments, the Disabled Students’ Allowance is available for the provision of more specialist support. For students with progressive neurological conditions, such as Friedreich’s ataxia, this may include assistive technology.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to establish a centralised dataset on localised ADHD assessment waiting times.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has recognised that, nationally, demand for assessments for attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support.
For the first time, NHS England published management information on ADHD assessment waiting times at a national level on 29 May 2025 as part of its ADHD data improvement plan. Data is now released each quarter with the latest release in August 2025.
Data on ADHD waiting times at an integrated care board (ICB) level is not currently held centrally. NHS England has released technical guidance to ICBs to improve the recording of ADHD data, with a view to improving data quality and publishing more localised data. NHS England intends to publish data at an ICB level in 2026/27.
My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD, and Autism. This independent review will inform our approach to enabling people with ADHD to have the right support in place to enable them to live well in their communities.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will make an estimate of the number of people with Parkinson's in the Employment and Support Allowance Support Group.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
As of May 2025, there were 2,000 claimants in the Employment and Support Allowance Support Group with the main disabling condition 'Parkinson’s disease or syndrome’. In the same month, there were 300 claimants in the Employment and Support Allowance Support Group with the main disabling condition ‘Parkinsonism’.
Data is based on primary medical condition as recorded on the ESA computer systems. Claimants may have multiple disabling conditions on which their entitlement is based but only the primary condition is available for statistical purposes and shown in these statistics.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he has made an assessment on the potential impact of vape flavour restrictions in (a) Canada, (b) Australia and (c) Netherlands on smoking cessation in the context of the proposed regulation of vape flavours in the United Kingdom.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The youth vaping call for evidence, published in 2023, demonstrated that vape flavours are one of the main reasons that vapes appeal to children. However, we recognise that vape flavours can also be a consideration for adult smokers seeking to quit smoking.
That is why it is important we strike the balance between restricting vape flavours to reduce their appeal to young people, whilst ensuring vapes remain available for adult smokers as a smoking cessation tool.
The Tobacco and Vapes Bill includes regulation making powers to limit vape flavours, to reduce the appeal to children. Before laying any regulations in Parliament, we will undertake a full public consultation to ensure we get this balance right and consider the views of a range of stakeholders. We will publish thorough impact assessments to accompany any future regulations, including future flavour restrictions. These assessments will consider the international evidence available.
In October 2025, we launched a call for evidence to gather information on flavours and substances in vaping, nicotine, and tobacco products, aiming to better understand the role and risks of flavourings and ingredients. The call for evidence also seeks to identify where efforts to control flavours have been effective or not.
Adult smokers will still be able to access vapes as well as alternative methods to support them to stop smoking. Vapes are commonly used alongside behavioural support within local Stop Smoking Services.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of scientific evidence on vape flavours as a smoking cessation aid.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The youth vaping call for evidence, published in 2023, demonstrated that vape flavours are one of the main reasons that vapes appeal to children. However, we recognise that vape flavours can also be a consideration for adult smokers seeking to quit smoking.
That is why it is important we strike the balance between restricting vape flavours to reduce their appeal to young people, whilst ensuring vapes remain available for adult smokers as a smoking cessation tool.
The Tobacco and Vapes Bill includes regulation making powers to limit vape flavours, to reduce the appeal to children. Before laying any regulations in Parliament, we will undertake a full public consultation to ensure we get this balance right and consider the views of a range of stakeholders. We will publish thorough impact assessments to accompany any future regulations, including future flavour restrictions. These assessments will consider the international evidence available.
In October 2025, we launched a call for evidence to gather information on flavours and substances in vaping, nicotine, and tobacco products, aiming to better understand the role and risks of flavourings and ingredients. The call for evidence also seeks to identify where efforts to control flavours have been effective or not.
Adult smokers will still be able to access vapes as well as alternative methods to support them to stop smoking. Vapes are commonly used alongside behavioural support within local Stop Smoking Services.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of flavoured vapes on tobacco smoking cessation.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The youth vaping call for evidence, published in 2023, demonstrated that vape flavours are one of the main reasons that vapes appeal to children. However, we recognise that vape flavours can also be a consideration for adult smokers seeking to quit smoking.
That is why it is important we strike the balance between restricting vape flavours to reduce their appeal to young people, whilst ensuring vapes remain available for adult smokers as a smoking cessation tool.
The Tobacco and Vapes Bill includes regulation making powers to limit vape flavours, to reduce the appeal to children. Before laying any regulations in Parliament, we will undertake a full public consultation to ensure we get this balance right and consider the views of a range of stakeholders. We will publish thorough impact assessments to accompany any future regulations, including future flavour restrictions. These assessments will consider the international evidence available.
In October 2025, we launched a call for evidence to gather information on flavours and substances in vaping, nicotine, and tobacco products, aiming to better understand the role and risks of flavourings and ingredients. The call for evidence also seeks to identify where efforts to control flavours have been effective or not.
Adult smokers will still be able to access vapes as well as alternative methods to support them to stop smoking. Vapes are commonly used alongside behavioural support within local Stop Smoking Services.
Asked by: Mary Glindon (Labour - Newcastle upon Tyne East and Wallsend)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve accessibility to (a) education and (b) healthcare for people with progressive neurological conditions such as Friedreich’s Ataxia.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving the lives of those living with rare diseases, such as Friedreich’s ataxia. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community, and these include: getting a final diagnosis faster; increasing awareness of rare diseases among healthcare professionals; better coordination of care; and improving access to specialist care, treatments, and drugs. In February we published the fourth England action plan reporting on progress.
NHS England has revised the national service specification for specialised neurology, which now includes an annex providing greater clarity for neurology sub-specialties. This includes the categories of both movement disorders and neurogenetics, into which Friedreich’s ataxia falls. Every specialised National Health Service neurology centre could and should see patients with Friedreich’s ataxia.
The NHS England Genomics Education Programme has also developed a range of educational resources for healthcare professionals. This includes a Knowledge Hub page on Friedreich ataxia, including information on presentation, diagnosis, management, and links for clinicians to further resources, which is available at the following link:
https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/friedreich-ataxia/